Login:
 
The Practitioner 2010 – 254 (1730): 7

Optimal medical therapy boosts one-year survival rates following acute MI

24 Jun 2010Pais-up subscribers

One-year mortality following MI can be significantly improved by giving patients a combination of five drug classes: aspirin, beta-blockers, statins, renin angiotensin system (RAS) blockers and thienopyridines. However, less than half of patients receive this optimal therapy, a study from Germany has shown. 'These findings should further reinforce our efforts to maximise the uptake of these drugs in our post-infarct populations. This should form a key part of cardiac rehabilitation and primary care chronic disease programmes.'

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article